NCT03802916 - Safety and Acceptability of Deferiprone Delayed Release Tablets in Patients With Systemic Iron Overload | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 6, 2019

Primary Completion Date

December 4, 2019

Study Completion Date

December 19, 2019

Conditions

Iron Overload Due to Repeated Red Blood Cell Transfusions

Interventions

DRUG

Deferiprone DR tablets 1000 mg (Low dosage)

Deferiprone DR tablets 1000 mg

DRUG

Deferiprone DR tablets 1000 mg (High dosage)

Deferiprone DR tablets 1000 mg

Trial Locations (5)

San Luigi Gonzaga University Hospital Reparto Microcitemie-Pediatria, Orbassano (TO)

New York Presbyterian Hospital/Weill Cornell Medical Center, New York

National and Kapodistrian University of Athens, Aghia Sophia Children's Hospital, Goudi

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

St.Paul's Hospital, Vancouver